Clinical Trials Sponsored by Beijing Tide Pharmaceutical Co., Ltd

Total 4402 results

Beijing Tide Pharmaceutical Co., Ltd

Not yet recruiting

A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough

Refractory Chronic Cough
Beijing Tide Pharmaceutical Co., Ltd

Recruiting

A Phase I/II Clinical Study in Patients With Advanced Solid Tumor.

Patients With Advanced Solid Tumors

China
Beijing Tide Pharmaceutical Co., Ltd

Not yet recruiting

TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))

GVHD, Chronic
Beijing Tide Pharmaceutical Co., Ltd

Not yet recruiting

A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis
Xijing Hospital of Digestive Diseases
Beijing Tide Pharmaceutical Co., Ltd

Completed

Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer

Esophageal Neoplasms

China
Beijing Tide Pharmaceutical Co., Ltd
Peking University First Hospital

Unknown

Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury

Myocardial Reperfusion Injury

China
Shandong New Time Pharmaceutical Co., LTD

Recruiting

Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors

Solid Tumors

China
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis

Osteoporosis

China
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

Study of F527 in Patients With Relapsed or Refractory Lymphoma

Relapsed/Refractory Lymphoma

China
Shandong New Time Pharmaceutical Co., LTD

Completed

A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

Efficacy and Safety

China
Shandong New Time Pharmaceutical Co., LTD

Unknown

A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma

Locally Advanced or Metastatic Urothelial Cell Carcinoma
Shandong New Time Pharmaceutical Co., LTD

Unknown

The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).

Peripheral T Cell Lymphoma
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NSCLC | Non-small Cell Lung Cancer | PD-1

China
Shandong New Time Pharmaceutical Co., LTD

Recruiting

the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCL

RR DLBCL; PD-1; CD20
Shandong New Time Pharmaceutical Co., LTD

Recruiting

A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients

Recruiting

China
Shandong New Time Pharmaceutical Co., LTD

Completed

A Phase IV Study of Huazhi Rougan Granule

A Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

China
Shandong New Time Pharmaceutical Co., LTD

Unknown

Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520

Advanced Solid Tumor，Recurrent Solid Tumor，Lymphoma，Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma

China
Shandong New Time Pharmaceutical Co., LTD

Recruiting

Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma

Dose-Escalation Study, Relapsed or Refractory Multiple Myeloma

China
Shandong New Time Pharmaceutical Co., LTD

Completed

A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma

Cervical Cancer

China
Shandong New Time Pharmaceutical Co., LTD

Completed

Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg

Bioequivalence

China
Shandong New Time Pharmaceutical Co., LTD

Unknown

A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL)

Primary Central Nervous System Lymphoma | Secondary Central Nervous System Lymphoma
Beijing Tide Pharmaceutical Co., Ltd
The Third Xiangya Hospital of Central South University

Not yet recruiting

Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery

Pain, Post-operative

China
Beijing Continent Pharmaceutical Co, Ltd.

Recruiting

F573 for Injection for the Treatment of Liver Injury/Failure

Acute-On-Chronic Liver Failure | Acute Liver Failure

China
Beijing Continent Pharmaceutical Co, Ltd.

Recruiting

Hydronidone for the Treatment of Liver Fibrosis Associated With Chronic Viral Hepatitis B Phase 3 Trial.

Liver Fibrosis

China
Beijing Konruns Pharmaceutical Co., Ltd.

Completed

A Food Effect Study of KC1036 in Healthy Subjects

Healthy Subjects

China
Beijing Continent Pharmaceutical Co, Ltd.

Recruiting

Hydroxynidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis

Liver Fibrosis

China
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of KC1036 in Patients With Advanced Thymic Tumors

Thymic Tumors

China
Beijing Continent Pharmaceutical Co, Ltd.

Not yet recruiting

Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis

Pneumoconiosis
Beijing Continent Pharmaceutical Co, Ltd.

Recruiting

Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics

Renal Insufficiency

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

F573 Ia Clinical Trial

Tolerance | Pharmacokinetic

China
Beijing Konruns Pharmaceutical Co., Ltd.

Completed

The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Chronic Pelvic Pain

China
Beijing Continent Pharmaceutical Co, Ltd.

Terminated

A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury.

Radiation-induced Lung Injury

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

Study on Pharmacokinetics of Hydronidone

Pharmacokinetics of Hydronidone

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects

Hydronidone

China
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer

Esophageal Squamous Cell Carcinoma

China
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Chronic Pelvic Pain

China
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

To Evaluate KC1036 in the Patients With Advanced Digestive System Tumors

Digestive System Tumors

China
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of KC1036 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

Study on PK of Hydronidone in Patients and Special Population

Hepatitis b & Liver Dysfunction

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

Study on Hydronidone Capsule BE

Healthy

China
Beijing Continent Pharmaceutical Co, Ltd.

Unknown

Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD)

Dermatomyositis Interstitial Lung Disease (Dm-ILD)

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Not yet recruiting

Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation

Atrial Fibrillation
Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Locally Advanced or Metastatic Non-Small Cell Lung Cancer

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Active, not recruiting

A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction

Brain Swelling, Large Hemispheric Infarction

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Active, not recruiting

Safety and Tolerability of SHR-1918 in Healthy Subjects

Hyperlipemia

China
Beijing Biostar Pharmaceuticals Co., Ltd.

Completed

Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer

Breast Cancer

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Beijing Suncadia Pharmaceuticals Co., Ltd

Not yet recruiting

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Homozygous Familial Hypercholesterolemia
Beijing Suncadia Pharmaceuticals Co., Ltd

Not yet recruiting

Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects

Diabetes

Clinical Trials Sponsored by Beijing Tide Pharmaceutical Co., Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations